Rapid molecular tests for Covid, FluAB, RSV and Strep A
16 followers
0 Likes
hello,
we have been using ID Now instruments for our rapid molecular detection of the common respiratory viruses and bacteria for years. Recently, we have received few requests from our providers to evaluate any other options in the world for 1 swab = 4 results (if possible). We have looked on Biofire (1 throat swab - Flu, RSV (yes from the throat swab), StrepA, Human Rhinovirus), Cobas Liat (few combos), and Cepheid (1NP swab=Covid, FLu,RSV). There are some pro and cons on all of them and we made a comparison table. Do you mind sharing if you have been using any other CLIA Waived/Interfaced platforms for rapid molecular tests? Also, would you mind sharing your experience with Biofire, Cobas Liat, Cepheid or ID Now. What do you like and what would you wish to change?
Any input or response is appreciated. Thank you for your time in advance.
we have been using ID Now instruments for our rapid molecular detection of the common respiratory viruses and bacteria for years. Recently, we have received few requests from our providers to evaluate any other options in the world for 1 swab = 4 results (if possible). We have looked on Biofire (1 throat swab - Flu, RSV (yes from the throat swab), StrepA, Human Rhinovirus), Cobas Liat (few combos), and Cepheid (1NP swab=Covid, FLu,RSV). There are some pro and cons on all of them and we made a comparison table. Do you mind sharing if you have been using any other CLIA Waived/Interfaced platforms for rapid molecular tests? Also, would you mind sharing your experience with Biofire, Cobas Liat, Cepheid or ID Now. What do you like and what would you wish to change?
Any input or response is appreciated. Thank you for your time in advance.
9 Replies
Reply
Subgroup Membership is required to post Replies
Join POCT Listserv now
Suggested Posts
Topic | Replies | Likes | Views | Participants | Last Reply |
---|---|---|---|---|---|
Verify Now IQCP | 0 | 0 | 95 | ||
i-STAT cTnI Interpretation and cutoff values | 2 | 0 | 140 | ||
Competency assessment clarification - mod and highly complex | 8 | 0 | 442 |
We have completed the primary validation for respiratory infection in our organization (LifeLabs/Canada). The CT values are comparable to those from the main lab devices (Seegene) for Covid, Flu A/B, and RSV. We are in the process of purchasing 10 Liat-Roche devices for PCR testing. The size is similar to a toaster, and each test will take 20 minutes to complete. Additionally, you can request three tests in one kit.
There is a new CLIA Waived Panel called RST Mini. RST stands for Respiratory Sore Throat and depending on the type of swab/specimen location, you can obtain a different set of results.
Using a NP swab and selecting that option on the instrument you will obtain the results for Flu A, Flu B, SARS-CoV-2, RSV, and Rhinovirus. We are expecting to receive Nasal Swab approval sometime in 2025.
Using a Throat Swab and selecting that option on the instrument, you can obtain results for Strep A, Flu A, Flu B, RSV, and Rhinovirus. All of these viral pathogens have a Sore Throat presentation.
We include Rhinovirus because it is the most prevalent viral pathogen during respiratory season and its inclusion can help aid in preventing unnecessary antibiotic prescriptions. We also offer a 15 pathogen bacterial and viral panel with an expanded syndromic approach but eh RST Mini is the most popular.
SPOTFIRE can be integrated into your LIS/EMR through interfacing directly or with the use of middleware.
We can also include at no additional charge, FIREWORKS, which is a cloud based data portal. You can remotely access all instrumentation from a phone, tablet, or laptop and review, download, and email results, review QC, get an accurate view of the number of tests run, and my favorite, pathogen surveillance. You can look back at 1 day, 1 week, or 4 weeks and with a simple hover obtain the positives detected for that time period. As well, we do not limit the number of licenses so your staff, and whoever you give access to, can obtain this information as well.
I hope this reply is not against the site rules. Please feel free to contact me directly with any questions here or at bruce.applebaum@biomerieux.com
We have listened to our customers and will hopefully be getting the Nasal Swab indication in 2025. Due to our 15 pathogen RST Panel having pertussis and additional bacterial pathogens, a nasopharyngeal swab was required. When we submitted for the full CLIA Waived status for RST Mini, we went with the NP swab so we can supply this product as non-EUA and bring it to the market faster. That being said, if SARS-CoV-2 is not a consideration, the Sore Throat Oral Swab portion of RST Mini may be of use.
Thank you again for your reply.